Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Tuesday Thirteen Inc. — Mirati Therapeutics, Inc. insider: 1 transactions · InsiderLens

Feed Screener Search Methodology

Pricing Sign in

Home / Insiders / Tuesday Thirteen Inc.

Tuesday Thirteen Inc.

10% owner at Mirati Therapeutics, Inc. · on record since Nov 22, 2017
10% owner at Esperion Therapeutics, Inc. · on record since Oct 30, 2018

Insider trading activity of Tuesday Thirteen Inc.

Transactions on record: 1; since Nov 22, 2017

Open-market buys: 0

Open-market sells: 1; $10.7K

Companies traded: 1; last filing Nov 22, 2017

Figures computed from official regulatory filings — methodology.

Companies where Tuesday Thirteen Inc. has traded

Mirati Therapeutics, Inc.1 tx · $10.7K · Nov 22, 2017

Track record of Tuesday Thirteen Inc.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Tuesday Thirteen Inc.

Co-insiders of Tuesday Thirteen Inc.

Boxer Asset Management Inc.Esperion Therapeutics, Inc. +1
Boxer Capital, LLCEsperion Therapeutics, Inc. +1
Braslyn Ltd.Esperion Therapeutics, Inc. +1
LEWIS JOSEPHEsperion Therapeutics, Inc. +1
667, L.P.Mirati Therapeutics, Inc.
Aghazadeh BehzadMirati Therapeutics, Inc.
Aisling Capital II LPEsperion Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

AISLING CAPITAL PARTNERS LLCEsperion Therapeutics, Inc.

AISLING CAPITAL PARTNERS, LPEsperion Therapeutics, Inc.

Alta Partners Management VIII, LLCEsperion Therapeutics, Inc.

Alta Partners VIII, L.P.Esperion Therapeutics, Inc.

Avoro Capital Advisors LLCMirati Therapeutics, Inc.

Baker Bros. Advisors (GP) LLCMirati Therapeutics, Inc.

BAKER BROS. ADVISORS LPMirati Therapeutics, Inc.

Baker Brothers Life Sciences LPMirati Therapeutics, Inc.

BAKER FELIXMirati Therapeutics, Inc.

BAKER JULIANMirati Therapeutics, Inc.

Bartram RichardEsperion Therapeutics, Inc.

BAUM CHARLES MMirati Therapeutics, Inc.

BAYH SUSAN BEsperion Therapeutics, Inc.

BB BIOTECH AGEsperion Therapeutics, Inc.

Berkley Capital Management Ltd.Mirati Therapeutics, Inc.

Berkowitz JeffreyEsperion Therapeutics, Inc.

BIOTECH TARGET N VEsperion Therapeutics, Inc.

BLAIR HENRY EEsperion Therapeutics, Inc.

BLAIR JAMES CEsperion Therapeutics, Inc.

Braunstein ScottEsperion Therapeutics, Inc.

BRINKERHOFF WILLIAM FEsperion Therapeutics, Inc.

Broadfin Capital, LLCMirati Therapeutics, Inc.

Broadfin Healthcare Master Fund LtdMirati Therapeutics, Inc.

CARROLL J MARTINEsperion Therapeutics, Inc.

CARTER BRUCE L AMirati Therapeutics, Inc.

CHAMPSI FARAHEsperion Therapeutics, Inc.

CHEN ISANMirati Therapeutics, Inc.

Cherrington Julie MMirati Therapeutics, Inc.

Christensen JamieMirati Therapeutics, Inc.

CRESSWELL RONALD MEsperion Therapeutics, Inc.

DASSEUX JEAN LOUIS HEsperion Therapeutics, Inc.

Davis Aaron I.Mirati Therapeutics, Inc.

Dissanayake Shehan BharathaMirati Therapeutics, Inc.

DOMAIN ASSOCIATESEsperion Therapeutics, Inc.

DOMAIN PARTERS VII L PEsperion Therapeutics, Inc.

Donadio Jamie AMirati Therapeutics, Inc.

DOVEY BRIAN HEsperion Therapeutics, Inc.

DP VII ASSOCIATES LPEsperion Therapeutics, Inc.

DURUS CAPITAL MANAGEMENTEsperion Therapeutics, Inc.

DURUS CAPITAL MANAGEMENT NA LLCEsperion Therapeutics, Inc.

DURUS LIFE SCIENCES MASTER FUND LTDEsperion Therapeutics, Inc.

EcoR1 Capital, LLCMirati Therapeutics, Inc.

ELMS STEVEEsperion Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Mirati Therapeutics, Inc.	Nov 22, 2017	Sell	-1,000	10.65 USD	$10.7K	SEC